financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Molson Coors Brewing Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Molson Coors Brewing Company
Apr 30, 2024 5:29 AM

08:05 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain a 12-month target of $75, based on a '25 P/E of 12.3x, a discount to TAP's 10-year mean forward P/E of 16.0x. We raise our adjusted EPS estimates to $6.00 from $5.70 for '24 and to $6.10 from $5.75 for '25. TAP posts Q1 adjusted EPS of $0.95 vs. $0.54 (+76%), well ahead of the $0.75 consensus. The beat was driven by stronger-than-expected sales and margins, as net sales rose 10.7% to $2.60B ($90M ahead of consensus), on improved price/sales mix (+4.4%) and higher financial volumes (+5.7%). Gross margin expanded 430 bps to 37.1% (150 bps above consensus). TAP maintained prior 2024 guidance, but we believe the forecast is likely to prove conservative following the strong Q1 results. TAP also repurchased 1.76M shares for $111M during Q1. We think TAP's results should alleviate concerns about more difficult comps, as its North American market share gains annualize. TAP's recent de-leveraging is notable, as its net debt/TTM EBITDA ratio fell to 2.3x at the end of Q1 versus 3.0x one year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Sep 11, 2025
02:50 AM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price of USD61, implying 16.3x our 2025 EPADS, a discount to historical forward P/E of 25x-30x to reflect growing concerns about long-term competitive positioning, yet above...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kkr & Co. Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kkr & Co. Inc.
Sep 10, 2025
01:45 PM EDT, 09/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $11 to $165 using a forward P/E 24.6x our 2026 earnings estimate, just below the five-year historical average at 26.9x and near direct peers....
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Chewy, Inc.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Chewy, Inc.
Sep 10, 2025
01:50 AM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $1 to $54, based on a blended valuation of 20x FY 27 (Jan.) EBITDA and 2.0x FY 27 EV/sales. We lift our FY 26...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Oracle Corp.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Oracle Corp.
Sep 10, 2025
09:00 AM EDT, 09/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We up our 12-month target to $350 from $256, on P/E of 36.8x our CY 27 EPS view of $9.50 above peers/historical to reflect the greater visibility/accelerating growth through the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved